Found: 21
Select item for more details and to access through your institution.
Multidrug-Resistant Tuberculosis in Europe, 2010-2011.
- Published in:
- Emerging Infectious Diseases, 2015, v. 21, n. 3, p. 409, doi. 10.3201/eid2103.141343
- By:
- Publication type:
- Article
Epidemiology of Mycobacterium bovis Disease in Humans, the Netherlands, 1993-2007.
- Published in:
- Emerging Infectious Diseases, 2011, v. 17, n. 3, p. 457, doi. 10.3201/eid1703.101111
- By:
- Publication type:
- Article
Mycobacterium xenopi Clinical Relevance and Determinants, the Netherlands.
- Published in:
- Emerging Infectious Diseases, 2008, v. 14, n. 3, p. 385, doi. 10.3201/eid1403.061393
- By:
- Publication type:
- Article
New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for Clinicians.
- Published in:
- Respiration, 2023, v. 102, n. 2, p. 83, doi. 10.1159/000528274
- By:
- Publication type:
- Article
Hypersensitivity pneumonitis caused by Mycobacterium avium subsp. hominissuis in a hot tub, as proven by IS1245 RFLP and rep-PCR typing
- Published in:
- International Journal of Mycobacteriology, 2012, v. 1, n. 3, p. 152, doi. 10.1016/j.ijmyco.2012.07.006
- By:
- Publication type:
- Article
Correction to: A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 7, p. 943, doi. 10.1007/s40262-020-00971-2
- By:
- Publication type:
- Article
The Antipsychotic Thioridazine Shows Promising Therapeutic Activity in a Mouse Model of Multidrug-Resistant Tuberculosis.
- Published in:
- PLoS ONE, 2010, v. 5, n. 9, p. 1, doi. 10.1371/journal.pone.0012640
- By:
- Publication type:
- Article
Prediction of Moxifloxacin Concentrations in Tuberculosis Patient Populations by Physiologically Based Pharmacokinetic Modeling.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 3, p. 385, doi. 10.1002/jcph.1972
- By:
- Publication type:
- Article
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.
- Published in:
- 2017
- By:
- Publication type:
- letter
A Step toward an Optimized Rifampin Dose Completed.
- Published in:
- 2015
- By:
- Publication type:
- letter
A Step toward an Optimized Rifampin Dose Completed.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 192, n. 4, p. 525, doi. 10.1164/rccm.201506-1061le
- By:
- Publication type:
- Article
A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 191, n. 9, p. 1058, doi. 10.1164/rccm.201407-1264OC
- By:
- Publication type:
- Article
A dose escalating trial to optimize the dose of rifampin in the treatment of tuberculosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 191, n. 9, p. E1, doi. 10.1164/rccm.201407-1264oc
- By:
- Publication type:
- Article
Optimal Sampling Strategies for Therapeutic Drug Monitoring of First-Line Tuberculosis Drugs in Patients with Tuberculosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin.
- Published in:
- 2019
- By:
- Publication type:
- journal article
High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre.
- Published in:
- PLoS ONE, 2019, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0213718
- By:
- Publication type:
- Article
A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 4, p. 1089, doi. 10.3390/pharmaceutics15041089
- By:
- Publication type:
- Article
Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 1, p. 9, doi. 10.3390/pharmaceutics15010009
- By:
- Publication type:
- Article